Table 4 Characteristics of the patients included in the propensity score-matched analysis

<Matched parameters>

n

15

15

Age*

63 ± 11

63 ± 11

0.923

Gender (male/female)

9/6

9/6

1.000

ECOG-PS*

0.7 ± 1.2

0.9 ± 1.1

0.758

Presence of distant metastasis (M+)

13 (87%)

12 (80%)

0.624

Thrombus level

0.624

Renal vein

7

6

I

1

2

II

4

2

III

2

3

IV

1

2

<Not matched parameters>

Clinical TN

cT3

15 (100%)

12 (80%)

0.068

cT4

0 (0%)

3 (20%)

cN+

5 (33%)

10 (66%)

0.068

Hemoglobin (g/dL)*

11 ± 2.4

11 ± 3.2

0.857

Neutrophil-lymphocyte ratio*

3.2 ± 1.5

3.5 ± 1.2

0.636

Serum albumin (g/dL)*

3.8 ± 0.5

3.6 ± 0.6

0.331

Renal function (ml/min./1.73 m²)*

60 ± 16

58 ± 20

0.756

Lactate dehydrogenase (LDH, IU/L)*

200 ± 57

279 ± 201

0.160

Choline esterase (U/L)*

240 ± 110

188 ± 107

0.213

Serum sodium (mEq/L)*

141 ± 1.9

139 ± 3.0

0.028

Correlated Calcium (mg/dL)*

9.9 ± 1.0

9.9 ± 0.7

0.977

C-reactive protein (CRP, mg/dL)*

6.0 ± 7.3

5.3 ± 4.6

0.787

Charlson comorbidity index*

10 ± 1.5

10 ± 2.5

0.864

Molecular targeted argents

6 (40%)

6 (40%)

1.000

Deceased

10 (67%)

11 (73%)

0.690